You have no items in your shopping cart.
Anti-CD52 [Alemtuzumab (Campath-1H)]
Description
Images & Validation
−| Tested Applications | ELISA, FC, IHC-Fr, IHC-P, WB |
|---|---|
| Reactivity | Human, Primate |
Key Properties
−| Host | Human |
|---|---|
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Clone No. | Alemtuzumab (Campath-1H) |
| Immunogen | Human lymphocytes. |
| Target | CD52 |
| Purity | Purified |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Buffer/Preservatives | PBS with 0.02% Proclin 300. |
| Concentration | 1 mg/ml |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Anti-CD52 [Alemtuzumab (Campath-1H)] [orb1152527]
ELISA, FC, IHC-Fr, IHC-P, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mgAnti-CD52 [Alemtuzumab (Campath-1H)] [orb348891]
ELISA, FC, IHC-Fr, IHC-P, WB
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348863_1.png)
Immunofluorescence staining of fixed rat thymus tissue with anti-CD52 antibody Campath-1H. Immunofluorescence analysis of fixed rat thymus tissue stained with the chimeric human IgG1 version of Campath-1H (orb348863) at 5 µg/ml followed by a FITC conjugated secondary antibody, showing membrane and cytoplasmic staining of a subset of cells. The nuclear stain is DAPI (blue). Panels show from left-right; orb348863 (FITC), DAPI and merged channels.
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348863_2.png)
Immunofluorescent staining of rat thymus using anti-CD52 antibody. Formaldehyde-fixed rat thymus slices were stained with orb348863 at 5 µg/ml and detected with a FITC-conjugated secondary antibody.
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348863_3.png)
Immunohistochemical staining of human thyroid cancer using anti-CD52 antibody. Formalin fixed human thyroid cancer slices were were stained with a orb348863 at 5 µg/ml.
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348863_4.png)
Immunohistochemical staining of rat epididymis tissue using anti-CD52 antibody Campath-1H. Anti-CD52 staining of formaldehyde fixed paraffin embedded rat epididymis tissue, at 40x magnification. The human IgG1-chimeric version of Campath-1H (orb348863) was used to stain samples at a concentration of 5 µg/ml.
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348863_5.png)
Immunohistochemical staining of rat spleen tissue using anti-CD52 antibody Campath-1H. Anti-CD52 staining of formaldehyde fixed paraffin embedded rat spleen tissue, at 40x magnification. The human IgG1-chimeric version of Campath-1H (orb348863) was used to stain samples at a concentration of 5 µg/ml.
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348863_6.png)
Immunohistochemical staining of rat thymus tissue using anti-CD52 antibody Campath-1H. Anti-CD52 staining of formaldehyde fixed paraffin embedded rat thymus tissue, at 40x magnification. The human IgG1-chimeric version of Campath-1H (orb348863) was used to stain samples at a concentration of 5 µg/ml.
Quick Database Links
UniProt Details
−Documents Download
Request a Document
Protocol Information
Anti-CD52 [Alemtuzumab (Campath-1H)] (orb348863)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_1.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_2.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_3.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_4.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_5.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_6.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_7.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb1152527_8.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348891_1.png)
![Anti-CD52 [Alemtuzumab (Campath-1H)]](/images/pub/media/catalog/product/NewWebsite/35/orb348891_2.png)